All Type of News
Government urged to promote genetic substitution
Korea needs to push up with a new prescription plan, under which doctors will be required to prescribe the active ingredient instead of the name of a specific drug product as they do now, according to the incumbent Ko...
Turf war brewing between medical doctors and oriental medicine doctors
The Korean Medical Association (KMA) strongly oriental medicine doctors making a claim to the government in its statement released last Sunday.
The Association of Korean Oriental Medicine (AKOM) has demanded the g...
Health authorities have no intention to re-evaluate efficacy of Ursa
The Ministry of Food and Drug Safety (MFDS) said it has not any plan to re-evaluate the efficacy of Ursa produced by Daewoong Pharm amid escalating dispute over the therapeutic effect of the liver function enhancer.
...
15 wholesalers to build large-scale drug logistics center in Busan
Busan Drug Distribution Cooperative announced Monday it will build a large-scale drug logistics center in the western area of Busan as part of its move to launch its joint drug logistics business.
A total of 15 dru...
Dream Pharma, Roche Korea starts strategic partnership
Dream Pharma, an affiliated company of Hanwha Group, said Tuesday that it has started a strategic partnership with Roche Korea is a Korean subsidiary of F. Hoffmann-La Roche, a research-focused healthcare company head...
Plan to change ‘generic drug’ in Korean draws mixed reactions
The Korea Pharmaceutical Manufacturers Association (KPMA) plans to change the name ‘generic drug’ in Korean to other appropriate name in an effort to dispel any negative public recognition and boost the sales of gener...
85,529 drug adverse events reported in first half
The number of adverse events from all medicines was recorded at 85,529 in the first half of this year, the Ministry of Food and Drug Safety (MFDS) said Tuesday.
The cases of drug side effects reported to the Korea ...
Prosecutors demand jail term for Dong-A’s sales executive
The prosecution on Monday demanded a 2-year jail term for Dong-A Pharmaceutical’s sales executive who was involved in the production of educational video for employees of Dong-A.
In the Seoul Central District Court...
Daewoong seeking to clarify controversial efficacy of Ursa
Daewoong Pharm is making all-out to publicize more correct information of Ursa (ursodeoxycholic acid; UCDA) to the public, while dispelling the local media’s recent report that Ursa is a simple digestive, being far fr...
Leading drug firm’s vice president is still in office
The sudden resignation of a top executive from one of the nation's leading drug companies has surprised the industry, but this was happening.
The industry is abuzz with speculation that Dongwha Pharm’s vice preside...
